CALDERA PHARMACEUTICALS, INC.
Grant: $178,915 - National Institutes of Health - Sep. 30, 2009
No votes have been cast for this award yet
Join the conversation: Post a comment about this award
Award Description: Caldera Pharmaceuticals will complete the necessary steps to commercialize its XRflo system. In Phase I we demonstrated the feasibility of this technique to measure unlabeled protein interactions in a fluidic system. XRflo allows for real-time, direct, label-free, quantitative, fluidic analysis of protein function. This project addresses fundamental challenges in proteomics. The goal of Phase II is to extend XRflo analysis to significantly more complex systems (including clinical specimens) and to prepare steps for commercialization of the instrument, device, software, and consumables.
Project Description: awarded 09/30/2009
Jobs Summary: PhD scientist (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Sep. 30, 2009. Help expand these official descriptions using the wiki below.
No comments have been added for this project.